Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase

Go back to Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase
(NASDAQ: RVMD) Delayed: 169.51 --0 (-0%)
Previous Close $169.51    52 Week High
Open $169.51    52 Week Low
Day High $169.51    P/E N/A 
Day Low $169.51    EPS
Volume 2,324